These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8667403)

  • 1. Immunity to Chlamydia trachomatis: lessons from a Gambian village.
    Mabey D; Bailey R
    J Med Microbiol; 1996 Jul; 45(1):1-2. PubMed ID: 8667403
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroepidemiologic study of Chlamydia pneumoniae and other chlamydial species in a hyperendemic area for trachoma in the Sudan.
    Mahmoud E; Elshibly S; Mardh PA
    Am J Trop Med Hyg; 1994 Oct; 51(4):489-94. PubMed ID: 7943577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia.
    Ward M; Bailey R; Lesley A; Kajbaf M; Robertson J; Mabey D
    Scand J Infect Dis Suppl; 1990; 69():137-48. PubMed ID: 2263890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma.
    Peeling RW; Bailey RL; Conway DJ; Holland MJ; Campbell AE; Jallow O; Whittle HC; Mabey DC
    J Infect Dis; 1998 Jan; 177(1):256-9. PubMed ID: 9419202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective.
    Bailey RL; Kajbaf M; Whittle HC; Ward ME; Mabey DC
    Epidemiol Infect; 1993 Oct; 111(2):315-24. PubMed ID: 8405158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models for ocular infections.
    Rank RG; Whittum-Hudson JA
    Methods Enzymol; 1994; 235():69-83. PubMed ID: 8057937
    [No Abstract]   [Full Text] [Related]  

  • 7. Profiling and validation of individual and patterns of Chlamydia trachomatis-specific antibody responses in trachomatous trichiasis.
    Pickering H; Burr SE; Derrick T; Makalo P; Joof H; Hayward RD; Holland MJ
    Parasit Vectors; 2017 Mar; 10(1):143. PubMed ID: 28288672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
    Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of trachoma in a Gambian village.
    Bailey RL; Hayes L; Pickett M; Whittle HC; Ward ME; Mabey DC
    Br J Ophthalmol; 1994 Nov; 78(11):813-7. PubMed ID: 7848974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger.
    Abdou A; Nassirou B; Kadri B; Moussa F; Munoz BE; Opong E; West SK
    Br J Ophthalmol; 2007 Jan; 91(1):13-7. PubMed ID: 16899525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease.
    Beatty WL; Byrne GI; Morrison RP
    Trends Microbiol; 1994 Mar; 2(3):94-8. PubMed ID: 8156277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic insights into local-scale evolution of ocular
    Ghasemian E; Faal N; Pickering H; Sillah A; Breuer J; Bailey RL; Mabey D; Holland MJ
    Microb Genom; 2024 Mar; 10(3):. PubMed ID: 38445851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The duration of human ocular Chlamydia trachomatis infection is age dependent.
    Bailey R; Duong T; Carpenter R; Whittle H; Mabey D
    Epidemiol Infect; 1999 Dec; 123(3):479-86. PubMed ID: 10694161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses and chlamydial infections.
    Monnickendam MA; Pearce JH
    Br Med Bull; 1983 Apr; 39(2):187-93. PubMed ID: 6347330
    [No Abstract]   [Full Text] [Related]  

  • 15. Trachoma research: it takes more than a village.
    Lietman TM; Neuwelt MD; Gandhi NG; Dalmon CA; Benitah N
    Lancet; 2006 Feb; 367(9508):395. PubMed ID: 16458760
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of immunity to ocular chlamydial infection.
    Taylor HR
    Am J Trop Med Hyg; 1990 Apr; 42(4):358-64. PubMed ID: 2331044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Presence of anti-Chlamydia antibodies in healthy children].
    Ottolenghi A; Clerici P; Finazzi E; Ciccone A; Magliano EM
    Pediatr Med Chir; 1986; 8(4):541-3. PubMed ID: 3575129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of trachoma among displaced persons in the Sudan: a clinical and sero-epidemiological study.
    Mahmoud EA; Sheikh AH; Domeika MA; Mårdh PA
    Eye (Lond); 1994; 8 ( Pt 1)():130-3. PubMed ID: 8013707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area.
    West S; Muñoz B; Bobo L; Quinn TC; Mkocha H; Lynch M; Mmbaga BB; Viscidi R
    Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3194-8. PubMed ID: 8407229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cell-mediated immunity in chlamydial infection: implications for ocular immunity.
    Williams DM; Schachter J
    Rev Infect Dis; 1985; 7(6):754-9. PubMed ID: 4070909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.